OncoCyte (OCX) S-3 Shelf registration

Exhibit 107

Calculation of Filing Fee Tables

Form S-3

Oncocyte Corporation

Table 1: Newly Registered and Carry Forward Securities

	Security Type	Security Class Title		Fee Calculation or Carry Forward Rule		Amount Registered (1)			Proposed Maximum Offering Price Per Unit			Maximum Aggregate Offering Price		Fee Rate		Amount of Registration Fee		Carry Forward Form Type		Carry Forward File Number		Carry Forward Initial effective date		Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward
Newly Registered Securities
Fees to Be Paid	Equity		Common Stock, no par value per share		Rule 457(c)		5,419,788	(2)	$	2.66	(3)	$	14,416,637	$	0.00014760	$	2,127.90
Fees Previously Paid
Carry Forward Securities
Carry Forward Securities	-		-		-		-						-						-		-		-		-
	Total Offering Amounts											$	14,416,637			$	2,127.90
	Total Fees Previously Paid																-
	Total Fee Offsets																-
	Net Fee Due															$	2,127.90

(1)	Pursuant to Rule 416 under the Securities Act of 1933 (the “Securities Act”), the shares being registered hereunder include such indeterminate number of shares of common stock as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions.
(2)	Represents (i) 5,076,900 PIPE shares (as defined in the registration statement), and (ii) 342,888 Pre-Funded Warrant Shares (as defined in the registration statement).
(3)	Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) under the Securities Act, based on the average of the high and low prices of the common stock as reported on The Nasdaq Capital Market on May 3, 2024, which such date is within five business days of the filing of this registration statement, of $2.66 per share.